• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROLLENIUM MEDICAL TECHNOLOGIES INC REVANESSE VERSA+ WITH LIDOCAINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROLLENIUM MEDICAL TECHNOLOGIES INC REVANESSE VERSA+ WITH LIDOCAINE Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Rash (2033); Swelling (2091); Reaction (2414)
Event Type  malfunction  
Event Description
The patient was injected with revanesse versa+ (19b045) by (b)(6) (rn) on (b)(6) 2019 into the lips.Total 1.0 ml of the product was injected, 0.8 ml to r and l mannequin lines and 0.2 ml to r and l upper lip vermillion border area.The patient began experiencing swelling on her face and lips approximately 5 days after revanesse versa+ injections.The symptoms continued with irregular, red itchy rash/welts on her torso and neck particularly in the early morning hours.Patient went to local emergency for a blood panel where nothing unusual was found and they prescribed the prednisone 20 mg and loratadine 10 mg medicines for her symptoms.On (b)(6) 2019 patient called nurse injector and informed her that she had to take the medicines daily to relive her symptoms.If she missed a day the breakout would return.Patient asked if nurse injector could reverse the product.Before starting for any other treatment, patient wanted to see an allergist so she went to the allergist on (b)(6) 2019, where nothing unusual was found.Patient came to see the nurse injector on (b)(6) 2019 and the nurse injector injected the same treatment sites with hyaluronidase, 1.5 ml to each side of her mannequin lines and 0.5 ml to each side of upper lip.After the hyaluronidase treatment, there were no breakouts and she did not take any medicines.On (b)(6) 2019 the patient replaced the dissolved filler with juvederm product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REVANESSE VERSA+ WITH LIDOCAINE
Type of Device
REVANESSE VERSA+ WITH LIDOCAINE
Manufacturer (Section D)
PROLLENIUM MEDICAL TECHNOLOGIES INC
138, industrial parkway north
aurora, L4G 4 C3
CA  L4G 4C3
Manufacturer (Section G)
PROLLENIUM MEDICAL TECHNOLOGIE INC
9121 anson way, suite 213
raleigh NC 27615
Manufacturer Contact
colin hall
138, industrial parkway north
aurora L4G 4-C3
CA   L4G 4C3
MDR Report Key8802608
MDR Text Key216219114
Report Number3004423487-2019-00007
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160042/S003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type user facility
Reporter Occupation Nurse
Type of Report Initial
Report Date 05/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/18/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/09/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/01/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age56 YR
-
-